Report Detail

Pharma & Healthcare Global Pharma and Health Care Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4615708
  • |
  • 02 September, 2024
  • |
  • Global
  • |
  • 126 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments.
Health products are vitamins, minerals, herbal medicines, homeopathic preparations, probiotics and even some traditional medicines are also prescribed by doctor or any equivalent physician.
In this report, we mainly study the pharma and healthcare product.
According to our (Global Info Research) latest study, the global Pharma and Health Care market size was valued at US$ 1337580 million in 2023 and is forecast to a readjusted size of USD 1743920 million by 2030 with a CAGR of 3.9% during review period.
North America is the largest consumption place, with a consumption market share nearly 50%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 25%.
Market competition is intense. The key players are Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., etc. The top five vendors held 20% of the market share.
This report is a detailed and comprehensive analysis for global Pharma and Health Care market. Both quantitative and qualitative analyses are presented by company, by region & country, by Format and by Prescription. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Pharma and Health Care market size and forecasts, in consumption value ($ Million), 2019-2030
Global Pharma and Health Care market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Pharma and Health Care market size and forecasts, by Format and by Prescription, in consumption value ($ Million), 2019-2030
Global Pharma and Health Care market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharma and Health Care
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharma and Health Care market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer, Sanofi, Takeda, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Pharma and Health Care market is split by Format and by Prescription. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Format and by Prescription. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Pharma and Health Care market is split by Format and by Prescription. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Format and by Prescription. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Format
Bottle
Blister
Others
Market segment by Prescription
OTC Drugs
Prescription Drugs
Market segment by players, this report covers
Johnson & Johnson
Novartis
Roche
AbbVie
Merck & Co.
Bristol Myers Squibb
GlaxoSmithKline
Pfizer
Sanofi
Takeda
AstraZeneca
Bayer
Eli Lilly & Co.
Gilead Sciences
Amgen
Novo Nordisk
Teva
Boehringer Ingelheim
Biogen
Astellas
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pharma and Health Care product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharma and Health Care, with revenue, gross margin, and global market share of Pharma and Health Care from 2019 to 2024.
Chapter 3, the Pharma and Health Care competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Format and by Prescription, with consumption value and growth rate by Format, by Prescription, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Pharma and Health Care market forecast, by regions, by Format and by Prescription, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharma and Health Care.
Chapter 13, to describe Pharma and Health Care research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Pharma and Health Care by Format
    • 1.3.1 Overview: Global Pharma and Health Care Market Size by Format: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Pharma and Health Care Consumption Value Market Share by Format in 2023
    • 1.3.3 Bottle
    • 1.3.4 Blister
    • 1.3.5 Others
  • 1.4 Global Pharma and Health Care Market by Prescription
    • 1.4.1 Overview: Global Pharma and Health Care Market Size by Prescription: 2019 Versus 2023 Versus 2030
    • 1.4.2 OTC Drugs
    • 1.4.3 Prescription Drugs
  • 1.5 Global Pharma and Health Care Market Size & Forecast
  • 1.6 Global Pharma and Health Care Market Size and Forecast by Region
    • 1.6.1 Global Pharma and Health Care Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Pharma and Health Care Market Size by Region, (2019-2030)
    • 1.6.3 North America Pharma and Health Care Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Pharma and Health Care Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Pharma and Health Care Market Size and Prospect (2019-2030)
    • 1.6.6 South America Pharma and Health Care Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Pharma and Health Care Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Johnson & Johnson
    • 2.1.1 Johnson & Johnson Details
    • 2.1.2 Johnson & Johnson Major Business
    • 2.1.3 Johnson & Johnson Pharma and Health Care Product and Solutions
    • 2.1.4 Johnson & Johnson Pharma and Health Care Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.2 Novartis
    • 2.2.1 Novartis Details
    • 2.2.2 Novartis Major Business
    • 2.2.3 Novartis Pharma and Health Care Product and Solutions
    • 2.2.4 Novartis Pharma and Health Care Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Novartis Recent Developments and Future Plans
  • 2.3 Roche
    • 2.3.1 Roche Details
    • 2.3.2 Roche Major Business
    • 2.3.3 Roche Pharma and Health Care Product and Solutions
    • 2.3.4 Roche Pharma and Health Care Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Roche Recent Developments and Future Plans
  • 2.4 AbbVie
    • 2.4.1 AbbVie Details
    • 2.4.2 AbbVie Major Business
    • 2.4.3 AbbVie Pharma and Health Care Product and Solutions
    • 2.4.4 AbbVie Pharma and Health Care Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 AbbVie Recent Developments and Future Plans
  • 2.5 Merck & Co.
    • 2.5.1 Merck & Co. Details
    • 2.5.2 Merck & Co. Major Business
    • 2.5.3 Merck & Co. Pharma and Health Care Product and Solutions
    • 2.5.4 Merck & Co. Pharma and Health Care Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Merck & Co. Recent Developments and Future Plans
  • 2.6 Bristol Myers Squibb
    • 2.6.1 Bristol Myers Squibb Details
    • 2.6.2 Bristol Myers Squibb Major Business
    • 2.6.3 Bristol Myers Squibb Pharma and Health Care Product and Solutions
    • 2.6.4 Bristol Myers Squibb Pharma and Health Care Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Bristol Myers Squibb Recent Developments and Future Plans
  • 2.7 GlaxoSmithKline
    • 2.7.1 GlaxoSmithKline Details
    • 2.7.2 GlaxoSmithKline Major Business
    • 2.7.3 GlaxoSmithKline Pharma and Health Care Product and Solutions
    • 2.7.4 GlaxoSmithKline Pharma and Health Care Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 GlaxoSmithKline Recent Developments and Future Plans
  • 2.8 Pfizer
    • 2.8.1 Pfizer Details
    • 2.8.2 Pfizer Major Business
    • 2.8.3 Pfizer Pharma and Health Care Product and Solutions
    • 2.8.4 Pfizer Pharma and Health Care Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Pfizer Recent Developments and Future Plans
  • 2.9 Sanofi
    • 2.9.1 Sanofi Details
    • 2.9.2 Sanofi Major Business
    • 2.9.3 Sanofi Pharma and Health Care Product and Solutions
    • 2.9.4 Sanofi Pharma and Health Care Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Sanofi Recent Developments and Future Plans
  • 2.10 Takeda
    • 2.10.1 Takeda Details
    • 2.10.2 Takeda Major Business
    • 2.10.3 Takeda Pharma and Health Care Product and Solutions
    • 2.10.4 Takeda Pharma and Health Care Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Takeda Recent Developments and Future Plans
  • 2.11 AstraZeneca
    • 2.11.1 AstraZeneca Details
    • 2.11.2 AstraZeneca Major Business
    • 2.11.3 AstraZeneca Pharma and Health Care Product and Solutions
    • 2.11.4 AstraZeneca Pharma and Health Care Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 AstraZeneca Recent Developments and Future Plans
  • 2.12 Bayer
    • 2.12.1 Bayer Details
    • 2.12.2 Bayer Major Business
    • 2.12.3 Bayer Pharma and Health Care Product and Solutions
    • 2.12.4 Bayer Pharma and Health Care Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Bayer Recent Developments and Future Plans
  • 2.13 Eli Lilly & Co.
    • 2.13.1 Eli Lilly & Co. Details
    • 2.13.2 Eli Lilly & Co. Major Business
    • 2.13.3 Eli Lilly & Co. Pharma and Health Care Product and Solutions
    • 2.13.4 Eli Lilly & Co. Pharma and Health Care Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Eli Lilly & Co. Recent Developments and Future Plans
  • 2.14 Gilead Sciences
    • 2.14.1 Gilead Sciences Details
    • 2.14.2 Gilead Sciences Major Business
    • 2.14.3 Gilead Sciences Pharma and Health Care Product and Solutions
    • 2.14.4 Gilead Sciences Pharma and Health Care Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Gilead Sciences Recent Developments and Future Plans
  • 2.15 Amgen
    • 2.15.1 Amgen Details
    • 2.15.2 Amgen Major Business
    • 2.15.3 Amgen Pharma and Health Care Product and Solutions
    • 2.15.4 Amgen Pharma and Health Care Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Amgen Recent Developments and Future Plans
  • 2.16 Novo Nordisk
    • 2.16.1 Novo Nordisk Details
    • 2.16.2 Novo Nordisk Major Business
    • 2.16.3 Novo Nordisk Pharma and Health Care Product and Solutions
    • 2.16.4 Novo Nordisk Pharma and Health Care Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Novo Nordisk Recent Developments and Future Plans
  • 2.17 Teva
    • 2.17.1 Teva Details
    • 2.17.2 Teva Major Business
    • 2.17.3 Teva Pharma and Health Care Product and Solutions
    • 2.17.4 Teva Pharma and Health Care Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 Teva Recent Developments and Future Plans
  • 2.18 Boehringer Ingelheim
    • 2.18.1 Boehringer Ingelheim Details
    • 2.18.2 Boehringer Ingelheim Major Business
    • 2.18.3 Boehringer Ingelheim Pharma and Health Care Product and Solutions
    • 2.18.4 Boehringer Ingelheim Pharma and Health Care Revenue, Gross Margin and Market Share (2019-2024)
    • 2.18.5 Boehringer Ingelheim Recent Developments and Future Plans
  • 2.19 Biogen
    • 2.19.1 Biogen Details
    • 2.19.2 Biogen Major Business
    • 2.19.3 Biogen Pharma and Health Care Product and Solutions
    • 2.19.4 Biogen Pharma and Health Care Revenue, Gross Margin and Market Share (2019-2024)
    • 2.19.5 Biogen Recent Developments and Future Plans
  • 2.20 Astellas
    • 2.20.1 Astellas Details
    • 2.20.2 Astellas Major Business
    • 2.20.3 Astellas Pharma and Health Care Product and Solutions
    • 2.20.4 Astellas Pharma and Health Care Revenue, Gross Margin and Market Share (2019-2024)
    • 2.20.5 Astellas Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Pharma and Health Care Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Pharma and Health Care by Company Revenue
    • 3.2.2 Top 3 Pharma and Health Care Players Market Share in 2023
    • 3.2.3 Top 6 Pharma and Health Care Players Market Share in 2023
  • 3.3 Pharma and Health Care Market: Overall Company Footprint Analysis
    • 3.3.1 Pharma and Health Care Market: Region Footprint
    • 3.3.2 Pharma and Health Care Market: Company Product Type Footprint
    • 3.3.3 Pharma and Health Care Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Format

  • 4.1 Global Pharma and Health Care Consumption Value and Market Share by Format (2019-2024)
  • 4.2 Global Pharma and Health Care Market Forecast by Format (2025-2030)

5 Market Size Segment by Prescription

  • 5.1 Global Pharma and Health Care Consumption Value Market Share by Prescription (2019-2024)
  • 5.2 Global Pharma and Health Care Market Forecast by Prescription (2025-2030)

6 North America

  • 6.1 North America Pharma and Health Care Consumption Value by Format (2019-2030)
  • 6.2 North America Pharma and Health Care Market Size by Prescription (2019-2030)
  • 6.3 North America Pharma and Health Care Market Size by Country
    • 6.3.1 North America Pharma and Health Care Consumption Value by Country (2019-2030)
    • 6.3.2 United States Pharma and Health Care Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Pharma and Health Care Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Pharma and Health Care Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Pharma and Health Care Consumption Value by Format (2019-2030)
  • 7.2 Europe Pharma and Health Care Consumption Value by Prescription (2019-2030)
  • 7.3 Europe Pharma and Health Care Market Size by Country
    • 7.3.1 Europe Pharma and Health Care Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Pharma and Health Care Market Size and Forecast (2019-2030)
    • 7.3.3 France Pharma and Health Care Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Pharma and Health Care Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Pharma and Health Care Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Pharma and Health Care Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Pharma and Health Care Consumption Value by Format (2019-2030)
  • 8.2 Asia-Pacific Pharma and Health Care Consumption Value by Prescription (2019-2030)
  • 8.3 Asia-Pacific Pharma and Health Care Market Size by Region
    • 8.3.1 Asia-Pacific Pharma and Health Care Consumption Value by Region (2019-2030)
    • 8.3.2 China Pharma and Health Care Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Pharma and Health Care Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Pharma and Health Care Market Size and Forecast (2019-2030)
    • 8.3.5 India Pharma and Health Care Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Pharma and Health Care Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Pharma and Health Care Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Pharma and Health Care Consumption Value by Format (2019-2030)
  • 9.2 South America Pharma and Health Care Consumption Value by Prescription (2019-2030)
  • 9.3 South America Pharma and Health Care Market Size by Country
    • 9.3.1 South America Pharma and Health Care Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Pharma and Health Care Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Pharma and Health Care Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Pharma and Health Care Consumption Value by Format (2019-2030)
  • 10.2 Middle East & Africa Pharma and Health Care Consumption Value by Prescription (2019-2030)
  • 10.3 Middle East & Africa Pharma and Health Care Market Size by Country
    • 10.3.1 Middle East & Africa Pharma and Health Care Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Pharma and Health Care Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Pharma and Health Care Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Pharma and Health Care Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Pharma and Health Care Market Drivers
  • 11.2 Pharma and Health Care Market Restraints
  • 11.3 Pharma and Health Care Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Pharma and Health Care Industry Chain
  • 12.2 Pharma and Health Care Upstream Analysis
  • 12.3 Pharma and Health Care Midstream Analysis
  • 12.4 Pharma and Health Care Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Pharma and Health Care. Industry analysis & Market Report on Pharma and Health Care is a syndicated market report, published as Global Pharma and Health Care Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Pharma and Health Care market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,208.56
    4,812.84
    6,417.12
    531,500.40
    797,250.60
    1,063,000.80
    292,737.60
    439,106.40
    585,475.20
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report